AEON Biopharma, Inc.

AEONAMEX • USD
0.14 USD
↘ 0.01 (8.04%)AT CLOSE (03:59 PM EST)
0.16
↗ 0.02 (15.85%)
POST MARKET (AS OF 07:59 PM EST)
Post Market
AS OF 07:59 PM EST
0.16
↗ 0.02 (15.85%)
🔴Market: CLOSED

AEON is currently priced at $0.14. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (355.6%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Nov 16, 2026.

Open?$0.15
High?$0.16
Low?$0.14
Prev. Close?$0.15
Volume?588.9K
Avg. Volume?1.1M
VWAP?$0.15
Rel. Volume?0.56x
Bid / Ask
Bid?$0.16 × 4.7K
Ask?$0.17 × 300
Spread?$0.01
Midpoint?$0.16
Valuation & Ratios
Market Cap?10.7M
Shares Out?71.5M
Float?11.4M
Float %?22.8%
P/E Ratio?N/A
P/B Ratio?-0.70
EPS?-$0.76
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Employees
8
Market Cap
10.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2023-07-24
Address
130 VANTIS DRIVE
ALISO VIEJO, CA 92656
Phone: (949) 354-6499
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
55
Piotroski F-Score?0/9Weak
Altman Z-Score?-126.06Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?23.37%Squeeze Risk
Short Interest?2.7M
Days to Cover?6.4
Free Float11.4M
Avg Daily Volume415.8K
Settlement Date2026-10-30
Financial Health
Current Ratio?0.54Weak
Quick Ratio?0.54Weak
Cash Ratio?0.47Low
Debt/Equity?-0.17Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-0.70CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.5CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
355.6%STRONG▾
ROA?
S&P
3
-924.3%WEAK▾
Cash Flow & Enterprise
FCF?$-13642000
Enterprise Value?$10.0M
Fundamentals ratios updated end of day